Optimal Just-in-Time Service Changing the Paradigm of Cancer Trials
First-patient-in milestone achieved in only two weeks with Cancer Treatment Centers of America WILMINGTON, N.C.–(BUSINESS WIRE)–Optimal Just-in-Time, a service of…
Pharmaceuticals, Biotechnology and Life Sciences
First-patient-in milestone achieved in only two weeks with Cancer Treatment Centers of America WILMINGTON, N.C.–(BUSINESS WIRE)–Optimal Just-in-Time, a service of…
Novartis said Tuesday that the USFDA marked its investigational sickle cell drug crizanlizumab for Priority Review, which could be the first monoclonal antibody targeting the P-selectin mediated multi-cellular adhesion in sickle cell disease.
-Submission Based on Pivotal Phase 2 Trial Results Recently Presented at Annual Meeting of American Society of Clinical Oncology- BOTHELL,…
DUBLIN–(BUSINESS WIRE)–The “FDA’s Regulation of Regenerative Medicine including Stem Cell Treatments and Tissue Engineering” training has been added to ResearchAndMarkets.com’s…
CLEVELAND–(BUSINESS WIRE)–Convelo Therapeutics, Inc., a biotechnology company with a mission to discover a new class of medicines that regenerate the…
Center for Veterinary Medicine to apply GastroPlus® to assess product bioequivalence in canines LANCASTER, Calif.–(BUSINESS WIRE)–Simulations Plus, Inc. (Nasdaq: SLP),…
WALTHAM, Mass.–(BUSINESS WIRE)–Axial Biotherapeutics, a biotechnology company dedicated to building a unique class of gut-targeted programs for neurodegenerative diseases and…
OTTAWA, Ontario–(BUSINESS WIRE)–#HR–Today, BioTalent Canada announced the launch of a new wage subsidy to support biotech companies in Canada’s green…
— Hugh Young Rienhoff, Jr., M.D., appointed as Chairman of the Board — Charles A. Johnson, M.D., appointed to Board…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV) today announced the publication of a manuscript in the peer-reviewed journal Spinal…